Understanding OUR Cytokine-Based Immunotherapy Candidates Our motivation extends to advancing a robust portfolio of programs geared toward growing the horizons of cytokine-based immunotherapy, especially for cancers where remedy possibilities remain limited. Use the links below to learn much more about our portfolio of cytokine-based immunotherapy candidates. Investigate Our Pipeline https://financefeeds.com/foresight-ventures-recognized-as-2024-top-5-most-active-copyright-vc/